Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.33 +0.12 (+5.49%)
As of: Sep 30, 2026 · 11:49 AM EDT

Xtl Biopharmaceuticals Ltd (XTLB) Operating Margin (2011 - 2024)

Updated

Xtl Biopharmaceuticals' Operating Margin came in at 202.42% for the quarter ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals Ltd (XTLB) Operating Margin (2011 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Xtl Biopharmaceuticals' Operating Margin was -171.84%.

  • Operating Margin carries a four-year change of +8446.34 percentage points (years ended Dec 2020 to Dec 2024).
  • Going back by year, Operating Margin was -8618.18% in the year ended Dec 31, 2020.
  • The figure for the quarter ended Dec 31, 2024 represents the highest quarterly Operating Margin in data going back to the quarter ended Jun 30, 2011.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 202.42%
Dec 31, 2020 -2,141.67%
Mar 31, 2020 -3,671.43%
Sep 30, 2014 -127.87%
Jun 30, 2014 -106.05%
Mar 31, 2014 -101.19%
Dec 31, 2013 104.36%
Sep 30, 2013 175.26%
Jun 30, 2013 -195.31%
Mar 31, 2013 -137.15%
Dec 31, 2012 -93.28%
Sep 30, 2012 -48.10%
Jun 30, 2012 -138.46%
Mar 31, 2012 28.06%
Dec 31, 2011 -38.56%
Sep 30, 2011 -114.37%
Jun 30, 2011 -67.41%
API Access

Xtl Biopharmaceuticals Ltd Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=XTLB&period=max&api_key=YOUR_API_KEY